Champions Oncology (CSBR) Tops Q3 EPS by 37c
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $5.18 +4.86%
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Cost of translational oncology solutions: 2.05M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q3 EPS of $0.36, $0.37 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $17 million versus the consensus estimate of $12.93 million.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue
- ScanSource (SCSC) Tops Q4 EPS by 32c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
